doi:10.19982/j.issn.1000-6621.20230277

Abstract

CLC Number:

Figures/Tables 4

References 25

[1]	牛军. CD8⁺T细胞受体谱系漂移在药物超敏反应综合征中的变化及其意义. 重庆:第三军医大学, 2015.
[2]	Deng QC, Fang X, Zeng QH, et al. Severe cutaneous adverse drug reaction of chinese inpatients:ameta-analysis. An Bras Dermatol, 2017, 92(3):345-349. doi:10.1590/abd1806-4841.2017.5171.
[3]	董传芳, 黄凤珍, 肖园园. 注射用美罗培南致老年人剥脱性皮炎一例. 中国药物与临床, 2021, 21(18):3206-3207. doi:10.11655/zgywylc2021.18.060.
[4]	李仁忠. 关于世界卫生组织广泛耐药结核病新定义的解读. 中国防痨杂志, 2021, 43(6):539-541. doi:10.3969/j.issn.1000-6621.2021.06.003.
[5]	张玉霞, 熊瑜, 常婷婷, 等. 含贝达喹啉方案治疗耐药肺结核的不良反应分析. 中国防痨杂志, 2022, 44(3):239-245. doi:10.19982/j.issn.1000-6621.20210702.
[6]	温雅, 代会敏, 王文华. 综合护理干预在呼吸系统重症患者护理中的应用效果. 实用医技杂志, 2021, 28(1):137-138. doi:10.19522/j.cnki.1671-5098.2021.01.072.
[7]	曹春玲, 王晓媛, 姚静. 1例剥脱性皮炎型药疹的皮肤护理. 中国实用护理杂志, 2005, 21(15):43-44. doi:10.3760/cma.j.issn.1672-7088.2005.15.027.
[8]	庄梦媛. 1例艾滋病合并重症剥脱性皮炎患者的护理. 当代护士(中旬刊), 2021, 28(12):158-159. doi:10.19793/j.cnki.1006-6411.2021.35.054.
[9]	王爱民. 36例重型药疹患者的观察与护理. 中华护理杂志, 2003, 38(11):895-897.
[10]	邵长庚, 靳培英. 红皮病的治疗进展. 中华皮肤科杂志, 2004, 37(3): 186-188.
[11]	张丽杰. 一例药物所致剥脱性皮炎患者的护理体会. 实用药物与临床, 2013, 16(11):1094-1096.
[12]	赵春云, 孙明, 詹宪玲. 5例剥脱性皮炎的护理体会. 中外医疗, 2011, 30(13):150,152. doi:10.3969/j.issn.1674-0742.2011.13.118.
[13]	杨晶, 周红革, 陈琼, 等. 1例红皮病高龄患者合并全身多处压疮的护理. 当代护士(下旬刊), 2019, 26(4):155-157.
[14]	杨龙飞, 宋冰, 倪翠萍, 等. 2019版《压力性损伤的预防和治疗:临床实践指南》更新解读. 中国护理管理, 2020(12):1849-1854. doi:10.3969/j.issn.1672-1756.2020.12.019.
[15]	张智辉, 彭亦通. 院内静脉血栓栓塞症防控的现状和策略. 广东医学, 2022, 43(3):271-275. doi:10.13820/j.cnki.gdyx.20212643.
[16]	马悦, 隆昌秀. 3例剥脱性皮炎型药疹患者的护理体会. 医药前沿, 2012, 2 (11):26. doi:10.3969/j.issn.2095-1752.2012.11.020.
[17]	邓秀芳, 蔡剑峰, 张学奇, 等. 291例药疹临床分析. 中华全科医学, 2011, 9(4):510-511,564.
[18]	方琴, 何勤, 赵红卫, 等. 重症药疹的治疗与护理. 护士进修杂志, 2004, 19(6):543-545. doi:10.3969/j.issn.1002-6975.2004.06.029.
[19]	石平荣, 段逸群. 药物超敏综合征8例临床分析. 中国麻风皮肤病杂志, 2007, 23(1):31-33. doi:10.3969/j.issn.1009-1157.2007.01.012.
[20]	王艳, 谢志宏, 胡云建, 等. 甲氧西林耐药的金黄色葡萄球菌感染一例并文献复习. 中华结核和呼吸杂志, 2009, 32(9):655-659. doi:10.3760/cma.j.issn.1001-0939.2009.09.006.
[21]	王杰, 杨存美, 马虹颖, 等. 1例2型糖尿病患者应用盐酸左氧氟沙星致重型剥脱性皮炎的护理. 护理学报, 2017, 24(14):56-57. doi:10.16460/j.issn1008-9969.2017.14.056.
[22]	孙倩倩, 叶红芳, 杨莉, 等. 接纳与承诺疗法对乳腺癌患者干预效果的Meta分析. 中华护理杂志, 2022, 57(9):1070-1079. doi:10.3761/j.issn.0254-1769.2022.09.007.
[23]	胡正祥, 卞徽宁, 马丹, 等. 中毒性表皮坏死松解症的临床特点及预后影响因素分析. 中华烧伤杂志, 2021, 37(8):738-746. doi:10.3760/cma.j.cn501120-20200416-00230.
[24]	蒲俐, 马登艳, 陈崇诚, 等. 1例口服别嘌醇致严重全身剥脱性皮炎病人的临床观察与护理. 护理研究, 2016, 30(5):638-639. doi:10.3969/j.issn.1009-6493.2016.05.044.
[25]	吴奇峰, 夏丽华, 梁伟辉, 等. 职业性三氯乙烯药疹样皮炎患者糖皮质激素使用方法分析. 中国职业医学, 2016, 43(6):633-638. doi:10.11763/j.issn.2095-2619.2016.06.001.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 4

References 25

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Li Min, Yao Yushan, Qiao Haixia, Lei Hong. Association between pulmonary tuberculosis and the gut microbiota: treatment strategies [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 520-526.
[2]	Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443.
[3]	Song Yunlin, Buzukela Abuduaini, Wang Guirong, Zhang Jiyuan, Lu Xiaobo. Research progresses on the role and mechanism of calcium-binding protein S100A12 and neutrophil extracellular trap formation in lung injury of severe pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 513-519.
[4]	Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415.
[5]	Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424.
[6]	An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438.
[7]	Li Leilei, Shi Lei, Wang Lin, Li Hongwei, Xu Liran, Pang Yu, Song Yanzheng. Clinical characteristics analysis of HIV-infected cases diagnosed with tuberculosis after surgery due to pulmonary nodules [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 266-273.
[8]	Gong Sheng, Wang Ning, Li Dan, Li Gang, Liu Yu, Jiang Liangshuang, Yao Xiaojun. Comparative study of fluorescence staining method and inflation-deflation method for thoracoscopic pulmonary tuberculosis segmentectomy [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 292-297.
[9]	Shi Yuru, Gu Dejian, Wu Jing, Liu Ting, Qin Linghan, Yue Li, Qi Yingjie. Diagnostic value of probe capture-based targeted next-generation sequencing and metagenomic next-generation sequencing for detecting Mycobacterium tuberculosis in bronchoalveolar lavage fluid [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 305-311.
[10]	Song Feier, Mao Yanjun, Xia Qiuyue, Zhou Yang, Lin Huan. The prevalence and influencing factors of post-tuberculosis lung disease: A Meta-analysis [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 322-330.
[11]	Yang Haixia, Zhang Xiaoyan, Huang Yi, Li Qiu. Effective and safety of concurrent intensity-modulated radiotherapy and anti-tuberculosis chemotherapy in patients with active pulmonary tuberculosis comorbid with thoracic tumor [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 312-321.
[12]	Li Xuelian, Zhang Hongyan, Wang Jun, Wang Qingfeng, Ma Liping, Chu Naihui, Nie Wenjuan. Safety of extended delamanid use in drug-resistant tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 164-168.
[13]	Gao Li, Chen Shengyu, Zhang Wenqian, Li Dan, Zhang Guoqin. Investigation on ability of conducting tuberculosis surveillance among four types of high-risk population in Tianjin public hospitals [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 195-200.
[14]	Wang Dafu, Ma Xiaoxue, Wang Yun, Li Fudong, Rao Wen, Gong Tingting, Li Shijun, Li Jinlan. Analysis of risk factors for patient delay and adverse treatment outcomes among patients with pulmonary tuberculosis and diabetes mellitus in Guizhou Province, 2016—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 201-209.
[15]	Qiu Yong, Quan Zhuo, Qu Rong, Tian Fajun, Li Meng, Wang Gengsheng, Wang Ya, Guo Mingcheng, Gao Qian. Evaluation of different tuberculosis diagnostic tools for detecting patients in a primary-level clinic in rural China: a real-world retrospective study [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 181-188.